Up until now uncultured bacteria have been an untapped source of new antibiotics, but promising research published in Nature yesterday highlights novel in-situ methods for growing uncultured microorganisms. One of
Academic publishing giant Elsevier have announced the forthcoming launch of a new open access multi-disciplinary scientific journal, calling for researchers to adopt a new collaborative and open source ethos. Dr.
Controversial DNA sequencing company 23andMe announced the first of 10 deals to be signed with large biotech and pharma firms on Tuesday January 6. Their $60 million partnership with Genentech
BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy BioReliance® (www.bioreliance.com), Sigma-Aldrich Corporation’s (NASDAQ: SIAL) biologics and early-development services business under SAFC® Commercial
Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry Merck to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx. $17 billion (€13.1 billion)
Lonza Half-Year Business Performance Fully on Track Business is fully on track with a CORE EBIT growth of 13.1% compared with the first half of 2013 despite currency headwinds Revenue
Roche delivers solid sales growth for the first nine months of 2014 Group sales up 5% at CER1, stable in Swiss francs 4% higher sales in Pharmaceuticals Division, with strong
Sigma-Aldrich (NASDAQ – SIAL) Reports Q3 2014 Results With Sales Of $690 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Per Share Quarterly Dividend. Q3 2014 Results (all percentage
Pacific Biosciences reported a 178% increase in revenue to $20.6 million for the third quarter ended September 30, 2014, compared to $7.4 million for the third quarter of 2013. Third
Company terminates existing sales agreement with BlueWave Healthcare Consultants Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today outlined
Beckman Coulter has received U.S. Food and Drug Administration (FDA) 510(k) clearance on its Power Express high-speed automated sample processing system. Designed to meet the needs of the most demanding
BD To Acquire CareFusion For $12.2 Billion BD and CareFusion announced a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a
Nine-month Figures for 2014: Sartorius Grows in Order Intake, Sales Revenue and Earnings Group sales revenue +9.6%; order intake +10.1%; underlying EBITDA +10.7% | Strong growth in the Bioprocess Solutions
